Clinical Trial

A Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of NKF-PEG, and US-Neulasta in Healthy Adult Male Volunteers

Name: A Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of NKF-PEG, and US-Neulasta in Healthy Adult Male Volunteers — clinical trial record (NCT07738991)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

A Single Center, Single-Dose, Double-Blind, Randomized, Two-Period, Crossover Study to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-PEG, and US-Neulasta®, and to Evaluate Safety in Healthy Adult Male Volunteers

Trial Details

NCT Number	NCT07738991
Lead Sponsor	Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
Conditions	Healthy Participants
Enrollment	202 participants
Start Date	2026-07-03
Primary Completion	2026-11-09 (estimated)
Study Completion	2027-04-12 (estimated)
Updated on ClinicalTrials.gov	2026-07-31